Michael Privitera - Concepedia

Author

Michael Privitera

Also Known As

Bulent Kara, Jannifer Cavitt, Kayla Darris, M D Privitera, M PRIVITERA, M Privitera, M. D. Privitera, M. Privitera, M.D PRIVITERA, M.D. Privitera

248

Publications

14.6K

Citations

H-Index

184

Concepts

All Affiliations

University of Cincinnati University of Cincinnati Medical Center Cincinnati Children's Hospital Medical Center University of Liverpool Emory University

About

Michael Privitera is an author at University of Cincinnati specializing in medicine, social sciences, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	57	7.4K
2	Health Sciences	3	3	99
3	Language Studies	2	2	25
4	Arts	1	1	15
5	Education	1	1	33

Michael Privitera

114

Publications

12.4K

Citations

H-Index

Page 1

	Year	Citations
Analysis of shared heritability in common disorders of the brain Verneri Anttila, Brendan Bulik‐Sullivan, Hilary K. Finucane, Science Brain FunctionPsychiatric DisordersGeneticsGenetic EpidemiologyNeuropsychiatry	2018	2K
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome Orrin Devinsky, Anup D. Patel, J. Helen Cross, New England Journal of Medicine	2018	948
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study Kimford J. Meador, Gus A. Baker, N. Andrew Browning, The Lancet Neurology Nead StudyNeuropsychological FunctioningNeuropsychologyPsychiatryEarly Life Exposure	2013	820
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs Kimford J. Meador, Gus A. Baker, N. Andrew Browning, New England Journal of Medicine	2009	812
Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies Bassel Abou‐Khalil, Pauls Auce, Andreja Avberšek, Nature Communications Epilepsy TherapiesGeneticsGenetic EpidemiologyMolecular GeneticsMonogenic Epilepsy Genes	2018	493
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages Michael Privitera, Richard W. Fincham, J. K. Penry, Neurology	1996	339
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy Mikko Muona, Samuel F. Berkovic, Leanne M. Dibbens, Nature Genetics GeneticsNeuroscienceCentral Nervous SystemMedicinePotassium Homeostasis	2014	311
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals Yen‐Chen Anne Feng, Daniel P. Howrigan, Liam Abbott, The American Journal of Human Genetics Allelic VariantUltra-rare Genetic VariationWhole-exome Sequencing StudyGeneticsGenetic Disorder	2019	298
EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness Michael Privitera, Michael Hoffman, James L. Moore, Epilepsy Research NeuropsychologyNeurophysiologyMedicineEeg Signal ProcessingNeurophysiological Biomarkers	1994	254
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy Michael Privitera, Martin J. Brodie, R. H. Mattson, Acta Neurologica Scandinavica	2003	247

Page 1